Global Syndromic Testing Supply, Demand and Key Producers, 2023-2029
The global Syndromic Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report studies the global Syndromic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Syndromic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Syndromic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Syndromic Testing total market, 2018-2029, (USD Million)
Global Syndromic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Syndromic Testing total market, key domestic companies and share, (USD Million)
Global Syndromic Testing revenue by player and market share 2018-2023, (USD Million)
Global Syndromic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Syndromic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Syndromic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics and Becton, Dickinson and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Syndromic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Syndromic Testing Market, By Region:
1. How big is the global Syndromic Testing market?
2. What is the demand of the global Syndromic Testing market?
3. What is the year over year growth of the global Syndromic Testing market?
4. What is the total value of the global Syndromic Testing market?
5. Who are the major players in the global Syndromic Testing market?
6. What are the growth factors driving the market demand?
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report studies the global Syndromic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Syndromic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Syndromic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Syndromic Testing total market, 2018-2029, (USD Million)
Global Syndromic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Syndromic Testing total market, key domestic companies and share, (USD Million)
Global Syndromic Testing revenue by player and market share 2018-2023, (USD Million)
Global Syndromic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Syndromic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Syndromic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics and Becton, Dickinson and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Syndromic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Syndromic Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Gastrointestinal Infections
- Central Nervous System Infections
- Others
- Outbreak Response
- Emergency Departments
- Travel Medicine
- Military Medicine
- Public Health Surveillance
- Thermo Fisher Scientific Inc.
- Qiagen
- Abbott Diagnostics
- Vela Diagnostics
- Veramarx
- Visby Medical
- XCR Diagnostics
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc
- Bosch Healthcare Solutions GmbH
- Genetic Signatures
- GenMark Dx (Roche)
- Hologic
- Roche Molecular Diagnostics
1. How big is the global Syndromic Testing market?
2. What is the demand of the global Syndromic Testing market?
3. What is the year over year growth of the global Syndromic Testing market?
4. What is the total value of the global Syndromic Testing market?
5. Who are the major players in the global Syndromic Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Syndromic Testing Introduction
1.2 World Syndromic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Syndromic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Syndromic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Syndromic Testing Market Size (2018-2029)
1.3.3 China Syndromic Testing Market Size (2018-2029)
1.3.4 Europe Syndromic Testing Market Size (2018-2029)
1.3.5 Japan Syndromic Testing Market Size (2018-2029)
1.3.6 South Korea Syndromic Testing Market Size (2018-2029)
1.3.7 ASEAN Syndromic Testing Market Size (2018-2029)
1.3.8 India Syndromic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Syndromic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Syndromic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Syndromic Testing Consumption Value (2018-2029)
2.2 World Syndromic Testing Consumption Value by Region
2.2.1 World Syndromic Testing Consumption Value by Region (2018-2023)
2.2.2 World Syndromic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Syndromic Testing Consumption Value (2018-2029)
2.4 China Syndromic Testing Consumption Value (2018-2029)
2.5 Europe Syndromic Testing Consumption Value (2018-2029)
2.6 Japan Syndromic Testing Consumption Value (2018-2029)
2.7 South Korea Syndromic Testing Consumption Value (2018-2029)
2.8 ASEAN Syndromic Testing Consumption Value (2018-2029)
2.9 India Syndromic Testing Consumption Value (2018-2029)
3 WORLD SYNDROMIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Syndromic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Syndromic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Syndromic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Syndromic Testing in 2022
3.3 Syndromic Testing Company Evaluation Quadrant
3.4 Syndromic Testing Market: Overall Company Footprint Analysis
3.4.1 Syndromic Testing Market: Region Footprint
3.4.2 Syndromic Testing Market: Company Product Type Footprint
3.4.3 Syndromic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Syndromic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Syndromic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Syndromic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Syndromic Testing Consumption Value Comparison
4.2.1 United States VS China: Syndromic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Syndromic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Syndromic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Syndromic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Syndromic Testing Revenue, (2018-2023)
4.4 China Based Companies Syndromic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Syndromic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Syndromic Testing Revenue, (2018-2023)
4.5 Rest of World Based Syndromic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Syndromic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Syndromic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Syndromic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Respiratory Infections
5.2.2 Sexually Transmitted Infections (STIs)
5.2.3 Gastrointestinal Infections
5.2.4 Central Nervous System Infections
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Syndromic Testing Market Size by Type (2018-2023)
5.3.2 World Syndromic Testing Market Size by Type (2024-2029)
5.3.3 World Syndromic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Syndromic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Outbreak Response
6.2.2 Emergency Departments
6.2.3 Travel Medicine
6.2.4 Military Medicine
6.2.5 Military Medicine
6.3 Market Segment by Application
6.3.1 World Syndromic Testing Market Size by Application (2018-2023)
6.3.2 World Syndromic Testing Market Size by Application (2024-2029)
6.3.3 World Syndromic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Details
7.1.2 Thermo Fisher Scientific Inc. Major Business
7.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Product and Services
7.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.2 Qiagen
7.2.1 Qiagen Details
7.2.2 Qiagen Major Business
7.2.3 Qiagen Syndromic Testing Product and Services
7.2.4 Qiagen Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Qiagen Recent Developments/Updates
7.2.6 Qiagen Competitive Strengths & Weaknesses
7.3 Abbott Diagnostics
7.3.1 Abbott Diagnostics Details
7.3.2 Abbott Diagnostics Major Business
7.3.3 Abbott Diagnostics Syndromic Testing Product and Services
7.3.4 Abbott Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Diagnostics Recent Developments/Updates
7.3.6 Abbott Diagnostics Competitive Strengths & Weaknesses
7.4 Vela Diagnostics
7.4.1 Vela Diagnostics Details
7.4.2 Vela Diagnostics Major Business
7.4.3 Vela Diagnostics Syndromic Testing Product and Services
7.4.4 Vela Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Vela Diagnostics Recent Developments/Updates
7.4.6 Vela Diagnostics Competitive Strengths & Weaknesses
7.5 Veramarx
7.5.1 Veramarx Details
7.5.2 Veramarx Major Business
7.5.3 Veramarx Syndromic Testing Product and Services
7.5.4 Veramarx Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Veramarx Recent Developments/Updates
7.5.6 Veramarx Competitive Strengths & Weaknesses
7.6 Visby Medical
7.6.1 Visby Medical Details
7.6.2 Visby Medical Major Business
7.6.3 Visby Medical Syndromic Testing Product and Services
7.6.4 Visby Medical Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Visby Medical Recent Developments/Updates
7.6.6 Visby Medical Competitive Strengths & Weaknesses
7.7 XCR Diagnostics
7.7.1 XCR Diagnostics Details
7.7.2 XCR Diagnostics Major Business
7.7.3 XCR Diagnostics Syndromic Testing Product and Services
7.7.4 XCR Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 XCR Diagnostics Recent Developments/Updates
7.7.6 XCR Diagnostics Competitive Strengths & Weaknesses
7.8 Beckman Coulter Diagnostics
7.8.1 Beckman Coulter Diagnostics Details
7.8.2 Beckman Coulter Diagnostics Major Business
7.8.3 Beckman Coulter Diagnostics Syndromic Testing Product and Services
7.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
7.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
7.9 Becton, Dickinson and Company
7.9.1 Becton, Dickinson and Company Details
7.9.2 Becton, Dickinson and Company Major Business
7.9.3 Becton, Dickinson and Company Syndromic Testing Product and Services
7.9.4 Becton, Dickinson and Company Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Becton, Dickinson and Company Recent Developments/Updates
7.9.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
7.10 Bio-Rad Laboratories, Inc
7.10.1 Bio-Rad Laboratories, Inc Details
7.10.2 Bio-Rad Laboratories, Inc Major Business
7.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Product and Services
7.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Bio-Rad Laboratories, Inc Recent Developments/Updates
7.10.6 Bio-Rad Laboratories, Inc Competitive Strengths & Weaknesses
7.11 Bosch Healthcare Solutions GmbH
7.11.1 Bosch Healthcare Solutions GmbH Details
7.11.2 Bosch Healthcare Solutions GmbH Major Business
7.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Product and Services
7.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bosch Healthcare Solutions GmbH Recent Developments/Updates
7.11.6 Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
7.12 Genetic Signatures
7.12.1 Genetic Signatures Details
7.12.2 Genetic Signatures Major Business
7.12.3 Genetic Signatures Syndromic Testing Product and Services
7.12.4 Genetic Signatures Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Genetic Signatures Recent Developments/Updates
7.12.6 Genetic Signatures Competitive Strengths & Weaknesses
7.13 GenMark Dx (Roche)
7.13.1 GenMark Dx (Roche) Details
7.13.2 GenMark Dx (Roche) Major Business
7.13.3 GenMark Dx (Roche) Syndromic Testing Product and Services
7.13.4 GenMark Dx (Roche) Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 GenMark Dx (Roche) Recent Developments/Updates
7.13.6 GenMark Dx (Roche) Competitive Strengths & Weaknesses
7.14 Hologic
7.14.1 Hologic Details
7.14.2 Hologic Major Business
7.14.3 Hologic Syndromic Testing Product and Services
7.14.4 Hologic Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hologic Recent Developments/Updates
7.14.6 Hologic Competitive Strengths & Weaknesses
7.15 Roche Molecular Diagnostics
7.15.1 Roche Molecular Diagnostics Details
7.15.2 Roche Molecular Diagnostics Major Business
7.15.3 Roche Molecular Diagnostics Syndromic Testing Product and Services
7.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Molecular Diagnostics Recent Developments/Updates
7.15.6 Roche Molecular Diagnostics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Syndromic Testing Industry Chain
8.2 Syndromic Testing Upstream Analysis
8.3 Syndromic Testing Midstream Analysis
8.4 Syndromic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Syndromic Testing Introduction
1.2 World Syndromic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Syndromic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Syndromic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Syndromic Testing Market Size (2018-2029)
1.3.3 China Syndromic Testing Market Size (2018-2029)
1.3.4 Europe Syndromic Testing Market Size (2018-2029)
1.3.5 Japan Syndromic Testing Market Size (2018-2029)
1.3.6 South Korea Syndromic Testing Market Size (2018-2029)
1.3.7 ASEAN Syndromic Testing Market Size (2018-2029)
1.3.8 India Syndromic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Syndromic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Syndromic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Syndromic Testing Consumption Value (2018-2029)
2.2 World Syndromic Testing Consumption Value by Region
2.2.1 World Syndromic Testing Consumption Value by Region (2018-2023)
2.2.2 World Syndromic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Syndromic Testing Consumption Value (2018-2029)
2.4 China Syndromic Testing Consumption Value (2018-2029)
2.5 Europe Syndromic Testing Consumption Value (2018-2029)
2.6 Japan Syndromic Testing Consumption Value (2018-2029)
2.7 South Korea Syndromic Testing Consumption Value (2018-2029)
2.8 ASEAN Syndromic Testing Consumption Value (2018-2029)
2.9 India Syndromic Testing Consumption Value (2018-2029)
3 WORLD SYNDROMIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Syndromic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Syndromic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Syndromic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Syndromic Testing in 2022
3.3 Syndromic Testing Company Evaluation Quadrant
3.4 Syndromic Testing Market: Overall Company Footprint Analysis
3.4.1 Syndromic Testing Market: Region Footprint
3.4.2 Syndromic Testing Market: Company Product Type Footprint
3.4.3 Syndromic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Syndromic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Syndromic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Syndromic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Syndromic Testing Consumption Value Comparison
4.2.1 United States VS China: Syndromic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Syndromic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Syndromic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Syndromic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Syndromic Testing Revenue, (2018-2023)
4.4 China Based Companies Syndromic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Syndromic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Syndromic Testing Revenue, (2018-2023)
4.5 Rest of World Based Syndromic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Syndromic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Syndromic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Syndromic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Respiratory Infections
5.2.2 Sexually Transmitted Infections (STIs)
5.2.3 Gastrointestinal Infections
5.2.4 Central Nervous System Infections
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Syndromic Testing Market Size by Type (2018-2023)
5.3.2 World Syndromic Testing Market Size by Type (2024-2029)
5.3.3 World Syndromic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Syndromic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Outbreak Response
6.2.2 Emergency Departments
6.2.3 Travel Medicine
6.2.4 Military Medicine
6.2.5 Military Medicine
6.3 Market Segment by Application
6.3.1 World Syndromic Testing Market Size by Application (2018-2023)
6.3.2 World Syndromic Testing Market Size by Application (2024-2029)
6.3.3 World Syndromic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Details
7.1.2 Thermo Fisher Scientific Inc. Major Business
7.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Product and Services
7.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.2 Qiagen
7.2.1 Qiagen Details
7.2.2 Qiagen Major Business
7.2.3 Qiagen Syndromic Testing Product and Services
7.2.4 Qiagen Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Qiagen Recent Developments/Updates
7.2.6 Qiagen Competitive Strengths & Weaknesses
7.3 Abbott Diagnostics
7.3.1 Abbott Diagnostics Details
7.3.2 Abbott Diagnostics Major Business
7.3.3 Abbott Diagnostics Syndromic Testing Product and Services
7.3.4 Abbott Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Diagnostics Recent Developments/Updates
7.3.6 Abbott Diagnostics Competitive Strengths & Weaknesses
7.4 Vela Diagnostics
7.4.1 Vela Diagnostics Details
7.4.2 Vela Diagnostics Major Business
7.4.3 Vela Diagnostics Syndromic Testing Product and Services
7.4.4 Vela Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Vela Diagnostics Recent Developments/Updates
7.4.6 Vela Diagnostics Competitive Strengths & Weaknesses
7.5 Veramarx
7.5.1 Veramarx Details
7.5.2 Veramarx Major Business
7.5.3 Veramarx Syndromic Testing Product and Services
7.5.4 Veramarx Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Veramarx Recent Developments/Updates
7.5.6 Veramarx Competitive Strengths & Weaknesses
7.6 Visby Medical
7.6.1 Visby Medical Details
7.6.2 Visby Medical Major Business
7.6.3 Visby Medical Syndromic Testing Product and Services
7.6.4 Visby Medical Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Visby Medical Recent Developments/Updates
7.6.6 Visby Medical Competitive Strengths & Weaknesses
7.7 XCR Diagnostics
7.7.1 XCR Diagnostics Details
7.7.2 XCR Diagnostics Major Business
7.7.3 XCR Diagnostics Syndromic Testing Product and Services
7.7.4 XCR Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 XCR Diagnostics Recent Developments/Updates
7.7.6 XCR Diagnostics Competitive Strengths & Weaknesses
7.8 Beckman Coulter Diagnostics
7.8.1 Beckman Coulter Diagnostics Details
7.8.2 Beckman Coulter Diagnostics Major Business
7.8.3 Beckman Coulter Diagnostics Syndromic Testing Product and Services
7.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
7.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
7.9 Becton, Dickinson and Company
7.9.1 Becton, Dickinson and Company Details
7.9.2 Becton, Dickinson and Company Major Business
7.9.3 Becton, Dickinson and Company Syndromic Testing Product and Services
7.9.4 Becton, Dickinson and Company Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Becton, Dickinson and Company Recent Developments/Updates
7.9.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
7.10 Bio-Rad Laboratories, Inc
7.10.1 Bio-Rad Laboratories, Inc Details
7.10.2 Bio-Rad Laboratories, Inc Major Business
7.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Product and Services
7.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Bio-Rad Laboratories, Inc Recent Developments/Updates
7.10.6 Bio-Rad Laboratories, Inc Competitive Strengths & Weaknesses
7.11 Bosch Healthcare Solutions GmbH
7.11.1 Bosch Healthcare Solutions GmbH Details
7.11.2 Bosch Healthcare Solutions GmbH Major Business
7.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Product and Services
7.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bosch Healthcare Solutions GmbH Recent Developments/Updates
7.11.6 Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
7.12 Genetic Signatures
7.12.1 Genetic Signatures Details
7.12.2 Genetic Signatures Major Business
7.12.3 Genetic Signatures Syndromic Testing Product and Services
7.12.4 Genetic Signatures Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Genetic Signatures Recent Developments/Updates
7.12.6 Genetic Signatures Competitive Strengths & Weaknesses
7.13 GenMark Dx (Roche)
7.13.1 GenMark Dx (Roche) Details
7.13.2 GenMark Dx (Roche) Major Business
7.13.3 GenMark Dx (Roche) Syndromic Testing Product and Services
7.13.4 GenMark Dx (Roche) Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 GenMark Dx (Roche) Recent Developments/Updates
7.13.6 GenMark Dx (Roche) Competitive Strengths & Weaknesses
7.14 Hologic
7.14.1 Hologic Details
7.14.2 Hologic Major Business
7.14.3 Hologic Syndromic Testing Product and Services
7.14.4 Hologic Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hologic Recent Developments/Updates
7.14.6 Hologic Competitive Strengths & Weaknesses
7.15 Roche Molecular Diagnostics
7.15.1 Roche Molecular Diagnostics Details
7.15.2 Roche Molecular Diagnostics Major Business
7.15.3 Roche Molecular Diagnostics Syndromic Testing Product and Services
7.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Molecular Diagnostics Recent Developments/Updates
7.15.6 Roche Molecular Diagnostics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Syndromic Testing Industry Chain
8.2 Syndromic Testing Upstream Analysis
8.3 Syndromic Testing Midstream Analysis
8.4 Syndromic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Syndromic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Syndromic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Syndromic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Syndromic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Syndromic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Syndromic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Syndromic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Syndromic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Syndromic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Syndromic Testing Players in 2022
Table 12. World Syndromic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Syndromic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Syndromic Testing Player
Table 15. Syndromic Testing Market: Company Product Type Footprint
Table 16. Syndromic Testing Market: Company Product Application Footprint
Table 17. Syndromic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Syndromic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Syndromic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Syndromic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 23. China Based Syndromic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Syndromic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 29. World Syndromic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Syndromic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Syndromic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Syndromic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Syndromic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Syndromic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Inc. Major Business
Table 37. Thermo Fisher Scientific Inc. Syndromic Testing Product and Services
Table 38. Thermo Fisher Scientific Inc. Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 40. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 41. Qiagen Basic Information, Area Served and Competitors
Table 42. Qiagen Major Business
Table 43. Qiagen Syndromic Testing Product and Services
Table 44. Qiagen Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Qiagen Recent Developments/Updates
Table 46. Qiagen Competitive Strengths & Weaknesses
Table 47. Abbott Diagnostics Basic Information, Area Served and Competitors
Table 48. Abbott Diagnostics Major Business
Table 49. Abbott Diagnostics Syndromic Testing Product and Services
Table 50. Abbott Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott Diagnostics Recent Developments/Updates
Table 52. Abbott Diagnostics Competitive Strengths & Weaknesses
Table 53. Vela Diagnostics Basic Information, Area Served and Competitors
Table 54. Vela Diagnostics Major Business
Table 55. Vela Diagnostics Syndromic Testing Product and Services
Table 56. Vela Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Vela Diagnostics Recent Developments/Updates
Table 58. Vela Diagnostics Competitive Strengths & Weaknesses
Table 59. Veramarx Basic Information, Area Served and Competitors
Table 60. Veramarx Major Business
Table 61. Veramarx Syndromic Testing Product and Services
Table 62. Veramarx Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Veramarx Recent Developments/Updates
Table 64. Veramarx Competitive Strengths & Weaknesses
Table 65. Visby Medical Basic Information, Area Served and Competitors
Table 66. Visby Medical Major Business
Table 67. Visby Medical Syndromic Testing Product and Services
Table 68. Visby Medical Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Visby Medical Recent Developments/Updates
Table 70. Visby Medical Competitive Strengths & Weaknesses
Table 71. XCR Diagnostics Basic Information, Area Served and Competitors
Table 72. XCR Diagnostics Major Business
Table 73. XCR Diagnostics Syndromic Testing Product and Services
Table 74. XCR Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. XCR Diagnostics Recent Developments/Updates
Table 76. XCR Diagnostics Competitive Strengths & Weaknesses
Table 77. Beckman Coulter Diagnostics Basic Information, Area Served and Competitors
Table 78. Beckman Coulter Diagnostics Major Business
Table 79. Beckman Coulter Diagnostics Syndromic Testing Product and Services
Table 80. Beckman Coulter Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Beckman Coulter Diagnostics Recent Developments/Updates
Table 82. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 83. Becton, Dickinson and Company Basic Information, Area Served and Competitors
Table 84. Becton, Dickinson and Company Major Business
Table 85. Becton, Dickinson and Company Syndromic Testing Product and Services
Table 86. Becton, Dickinson and Company Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Becton, Dickinson and Company Recent Developments/Updates
Table 88. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 89. Bio-Rad Laboratories, Inc Basic Information, Area Served and Competitors
Table 90. Bio-Rad Laboratories, Inc Major Business
Table 91. Bio-Rad Laboratories, Inc Syndromic Testing Product and Services
Table 92. Bio-Rad Laboratories, Inc Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Bio-Rad Laboratories, Inc Recent Developments/Updates
Table 94. Bio-Rad Laboratories, Inc Competitive Strengths & Weaknesses
Table 95. Bosch Healthcare Solutions GmbH Basic Information, Area Served and Competitors
Table 96. Bosch Healthcare Solutions GmbH Major Business
Table 97. Bosch Healthcare Solutions GmbH Syndromic Testing Product and Services
Table 98. Bosch Healthcare Solutions GmbH Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bosch Healthcare Solutions GmbH Recent Developments/Updates
Table 100. Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
Table 101. Genetic Signatures Basic Information, Area Served and Competitors
Table 102. Genetic Signatures Major Business
Table 103. Genetic Signatures Syndromic Testing Product and Services
Table 104. Genetic Signatures Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Genetic Signatures Recent Developments/Updates
Table 106. Genetic Signatures Competitive Strengths & Weaknesses
Table 107. GenMark Dx (Roche) Basic Information, Area Served and Competitors
Table 108. GenMark Dx (Roche) Major Business
Table 109. GenMark Dx (Roche) Syndromic Testing Product and Services
Table 110. GenMark Dx (Roche) Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. GenMark Dx (Roche) Recent Developments/Updates
Table 112. GenMark Dx (Roche) Competitive Strengths & Weaknesses
Table 113. Hologic Basic Information, Area Served and Competitors
Table 114. Hologic Major Business
Table 115. Hologic Syndromic Testing Product and Services
Table 116. Hologic Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hologic Recent Developments/Updates
Table 118. Roche Molecular Diagnostics Basic Information, Area Served and Competitors
Table 119. Roche Molecular Diagnostics Major Business
Table 120. Roche Molecular Diagnostics Syndromic Testing Product and Services
Table 121. Roche Molecular Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Syndromic Testing Upstream (Raw Materials)
Table 123. Syndromic Testing Typical Customers
Table 1. World Syndromic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Syndromic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Syndromic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Syndromic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Syndromic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Syndromic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Syndromic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Syndromic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Syndromic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Syndromic Testing Players in 2022
Table 12. World Syndromic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Syndromic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Syndromic Testing Player
Table 15. Syndromic Testing Market: Company Product Type Footprint
Table 16. Syndromic Testing Market: Company Product Application Footprint
Table 17. Syndromic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Syndromic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Syndromic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Syndromic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 23. China Based Syndromic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Syndromic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Syndromic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Syndromic Testing Revenue Market Share (2018-2023)
Table 29. World Syndromic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Syndromic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Syndromic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Syndromic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Syndromic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Syndromic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Inc. Major Business
Table 37. Thermo Fisher Scientific Inc. Syndromic Testing Product and Services
Table 38. Thermo Fisher Scientific Inc. Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 40. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 41. Qiagen Basic Information, Area Served and Competitors
Table 42. Qiagen Major Business
Table 43. Qiagen Syndromic Testing Product and Services
Table 44. Qiagen Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Qiagen Recent Developments/Updates
Table 46. Qiagen Competitive Strengths & Weaknesses
Table 47. Abbott Diagnostics Basic Information, Area Served and Competitors
Table 48. Abbott Diagnostics Major Business
Table 49. Abbott Diagnostics Syndromic Testing Product and Services
Table 50. Abbott Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott Diagnostics Recent Developments/Updates
Table 52. Abbott Diagnostics Competitive Strengths & Weaknesses
Table 53. Vela Diagnostics Basic Information, Area Served and Competitors
Table 54. Vela Diagnostics Major Business
Table 55. Vela Diagnostics Syndromic Testing Product and Services
Table 56. Vela Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Vela Diagnostics Recent Developments/Updates
Table 58. Vela Diagnostics Competitive Strengths & Weaknesses
Table 59. Veramarx Basic Information, Area Served and Competitors
Table 60. Veramarx Major Business
Table 61. Veramarx Syndromic Testing Product and Services
Table 62. Veramarx Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Veramarx Recent Developments/Updates
Table 64. Veramarx Competitive Strengths & Weaknesses
Table 65. Visby Medical Basic Information, Area Served and Competitors
Table 66. Visby Medical Major Business
Table 67. Visby Medical Syndromic Testing Product and Services
Table 68. Visby Medical Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Visby Medical Recent Developments/Updates
Table 70. Visby Medical Competitive Strengths & Weaknesses
Table 71. XCR Diagnostics Basic Information, Area Served and Competitors
Table 72. XCR Diagnostics Major Business
Table 73. XCR Diagnostics Syndromic Testing Product and Services
Table 74. XCR Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. XCR Diagnostics Recent Developments/Updates
Table 76. XCR Diagnostics Competitive Strengths & Weaknesses
Table 77. Beckman Coulter Diagnostics Basic Information, Area Served and Competitors
Table 78. Beckman Coulter Diagnostics Major Business
Table 79. Beckman Coulter Diagnostics Syndromic Testing Product and Services
Table 80. Beckman Coulter Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Beckman Coulter Diagnostics Recent Developments/Updates
Table 82. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 83. Becton, Dickinson and Company Basic Information, Area Served and Competitors
Table 84. Becton, Dickinson and Company Major Business
Table 85. Becton, Dickinson and Company Syndromic Testing Product and Services
Table 86. Becton, Dickinson and Company Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Becton, Dickinson and Company Recent Developments/Updates
Table 88. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 89. Bio-Rad Laboratories, Inc Basic Information, Area Served and Competitors
Table 90. Bio-Rad Laboratories, Inc Major Business
Table 91. Bio-Rad Laboratories, Inc Syndromic Testing Product and Services
Table 92. Bio-Rad Laboratories, Inc Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Bio-Rad Laboratories, Inc Recent Developments/Updates
Table 94. Bio-Rad Laboratories, Inc Competitive Strengths & Weaknesses
Table 95. Bosch Healthcare Solutions GmbH Basic Information, Area Served and Competitors
Table 96. Bosch Healthcare Solutions GmbH Major Business
Table 97. Bosch Healthcare Solutions GmbH Syndromic Testing Product and Services
Table 98. Bosch Healthcare Solutions GmbH Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bosch Healthcare Solutions GmbH Recent Developments/Updates
Table 100. Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
Table 101. Genetic Signatures Basic Information, Area Served and Competitors
Table 102. Genetic Signatures Major Business
Table 103. Genetic Signatures Syndromic Testing Product and Services
Table 104. Genetic Signatures Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Genetic Signatures Recent Developments/Updates
Table 106. Genetic Signatures Competitive Strengths & Weaknesses
Table 107. GenMark Dx (Roche) Basic Information, Area Served and Competitors
Table 108. GenMark Dx (Roche) Major Business
Table 109. GenMark Dx (Roche) Syndromic Testing Product and Services
Table 110. GenMark Dx (Roche) Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. GenMark Dx (Roche) Recent Developments/Updates
Table 112. GenMark Dx (Roche) Competitive Strengths & Weaknesses
Table 113. Hologic Basic Information, Area Served and Competitors
Table 114. Hologic Major Business
Table 115. Hologic Syndromic Testing Product and Services
Table 116. Hologic Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hologic Recent Developments/Updates
Table 118. Roche Molecular Diagnostics Basic Information, Area Served and Competitors
Table 119. Roche Molecular Diagnostics Major Business
Table 120. Roche Molecular Diagnostics Syndromic Testing Product and Services
Table 121. Roche Molecular Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Syndromic Testing Upstream (Raw Materials)
Table 123. Syndromic Testing Typical Customers
LIST OF FIGURES
Figure 1. Syndromic Testing Picture
Figure 2. World Syndromic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Syndromic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Syndromic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Syndromic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Syndromic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Syndromic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Syndromic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Syndromic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Syndromic Testing Markets in 2022
Figure 27. United States VS China: Syndromic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Syndromic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Syndromic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Syndromic Testing Market Size Market Share by Type in 2022
Figure 31. Respiratory Infections
Figure 32. Sexually Transmitted Infections (STIs)
Figure 33. Gastrointestinal Infections
Figure 34. Central Nervous System Infections
Figure 35. Others
Figure 36. World Syndromic Testing Market Size Market Share by Type (2018-2029)
Figure 37. World Syndromic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Syndromic Testing Market Size Market Share by Application in 2022
Figure 39. Outbreak Response
Figure 40. Emergency Departments
Figure 41. Travel Medicine
Figure 42. Military Medicine
Figure 43. Public Health Surveillance
Figure 44. Syndromic Testing Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. Syndromic Testing Picture
Figure 2. World Syndromic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Syndromic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Syndromic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Syndromic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Syndromic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Syndromic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Syndromic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Syndromic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Syndromic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Syndromic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Syndromic Testing Markets in 2022
Figure 27. United States VS China: Syndromic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Syndromic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Syndromic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Syndromic Testing Market Size Market Share by Type in 2022
Figure 31. Respiratory Infections
Figure 32. Sexually Transmitted Infections (STIs)
Figure 33. Gastrointestinal Infections
Figure 34. Central Nervous System Infections
Figure 35. Others
Figure 36. World Syndromic Testing Market Size Market Share by Type (2018-2029)
Figure 37. World Syndromic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Syndromic Testing Market Size Market Share by Application in 2022
Figure 39. Outbreak Response
Figure 40. Emergency Departments
Figure 41. Travel Medicine
Figure 42. Military Medicine
Figure 43. Public Health Surveillance
Figure 44. Syndromic Testing Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
